Cargando…

Screening breast cancer patients for Norwegian ATM mutations

Mostrar otras versiones (1)

483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated (ATM) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laake, K, Vu, P, Andersen, T I, Erikstein, B, Kåresen, R, Lønning, P E, Skovlund, E, Børresen-Dale, A L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363448/ https://www.ncbi.nlm.nih.gov/pubmed/11104561 http://dx.doi.org/10.1054/bjoc.2000.1519

Ejemplares similares

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

DHPLC Screening of ATM Gene in Italian Patients Affected by Ataxia-Telangiectasia: Fourteen Novel ATM Mutations
por: Magliozzi, Monia, et al.
Publicado: (2006)

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
por: Bebb, D G, et al.
Publicado: (1999)

Risk of breast cancer among Norwegian women with visual impairment
por: Kliukiene, J, et al.
Publicado: (2001)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer
por: Helle, S I, et al.
Publicado: (2001)

Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer
por: Helle, S I, et al.
Publicado: (2001)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women
por: Cyr, P.R., et al.
Publicado: (2021)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004)

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
por: Bernstein, Jonine L, et al.
Publicado: (2002)

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
por: Edvardsen, Hege, et al.
Publicado: (2007)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
por: Drageset, V, et al.
Publicado: (2005)

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer
por: Akslen, L A, et al.
Publicado: (2011)

European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables
por: Launonen, V, et al.
Publicado: (1999)

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
por: Peelen, T, et al.
Publicado: (2000)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006)

ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes
por: Delia, D, et al.
Publicado: (2000)

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers
por: Berge, Elisabet Ognedal, et al.
Publicado: (2010)

Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
por: Hartmann-Johnsen, Olaf Johan, et al.
Publicado: (2017)

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
por: Dumeaux, Vanessa, et al.
Publicado: (2008)

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
por: Knappskog, Stian, et al.
Publicado: (2012)

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer
por: Bernstein, J L, et al.
Publicado: (2003)

Fertility in Norwegian testicular cancer patients
por: Fosså, S D, et al.
Publicado: (2000)

Exploring nurse managers’ perception of using the RAFAELA system as a management tool in a Norwegian hospital setting
por: Lillehol, Bodil Mørk, et al.
Publicado: (2017)

ATM gene mutations in sporadic breast cancer patients from Brazil
por: Mangone, Flavia Rotea, et al.
Publicado: (2015)

Objectively measured physical activity level and sedentary behavior in Norwegian children during a week in preschool()
por: Andersen, Eivind, et al.
Publicado: (2017)

Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
por: Hartmann-Johnsen, Olaf Johan, et al.
Publicado: (2015)

Strong association between cervical and breast cancer screening behaviour among Danish women; A register-based cohort study
por: Larsen, S.H., et al.
Publicado: (2018)

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.
por: Appleby, J. M., et al.
Publicado: (1997)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Interval cancers in the Dutch breast cancer screening programme
por: Fracheboud, J, et al.
Publicado: (1999)

ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers
por: Abdel-Fatah, Tarek M.A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3tl46otn20aj5rakvkl6v22q27